San Diego, California (April 28, 2014)—Creato announced the successful completion of a pilot program with The University of Michigan Department of Health Management and Policy to test the viability of integrating Creato's Lean online training program with the graduate program curriculum. Ten first-year students from within the graduate program were selected to test Creato's product during the health care quality course.
Success criteria from the pilot included student's acknowledgement that the Creato program effectively complemented their classroom lectures and related assignments. Also, students were asked if they believed the Creato program equipped them for a more successful summer internship, or first employment opportunity.
"Overall, I think this has been a fantastic experience," noted one student in the pilot. "The material was exhaustive and thorough," noted another. "It set a framework for how projects should be developed and I believe this will definitely help me in the future of process improvement efforts at the workplace." Feedback from all participating students was universally positive.
"We were delighted to have this opportunity to support the Michigan program and thrilled to hear the student's enthusiasm for our product," notes Ian R. Lazarus, Managing Partner for Creato. "This simply reinforces our view that our academic content can rise to the standards of even the most respected universities."
About Creato: Creato Performance Solutions (www.creato.com) has been providing technologies and training to support corporate performance improvement for nearly 20 years. Today, Creato is a leading provider of Lean and Six Sigma deployment, and Project Portfolio Management products including the COMPASS® Quality Management System. Their combined classroom and online training programs are available through the American Society for Quality (ASQ), and a variety of other channel partners across the U.S. A recent study of 150 projects completed by Creato clients over the past 10 years revealed an average return on investment of 7:1.
# # #